|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 09768284.3 (espacenet) (Federated) (European Patent Register), 20091203 | | Patent/reg. no. and date | DK/EP 2364137, 20170329 | | Publication date | 20110914 | | Priority no. and date | US 120081 P, 20081205 | | EP pub. no. and date |
EP 2364137 20110914 | | Effective date | | | Applicant/owner | NOVARTIS AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/155344 | | Inventor | KABRA, Bhagwati P., 2205 Eagles Nest Drive
Euless
Texas 76039, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K, DK | | Opponent | | | IPC Class | A61K 47/10 (2017.01) , A61K 9/00 (2006.01) , A61K 9/10 (2006.01) | | Title | Farmaceutisk suspension | | Int. application no. | US2009066570 | | Int. publication no. | WO2010065730 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
